UNITY to hold investor and analyst conference call today, Monday, August 17, 2020, at 8:00 a.m. EDT SOUTH SAN FRANCISCO, Calif., Aug. 17, 2020 (GLOBE NEWSWIRE ...
SAN FRANCISCO, Jan. 22, 2019 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing, halting or reversing ...
New System Facilitates Ligament Balancing, Soft Tissue Preservation to Improve Joint Stability and Function, Minimize Pain After Total Knee Replacement Corin Group, a global orthopedic manufacturer ...
SAN FRANCISCO, Oct. 31, 2019 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to slow, halt or reverse diseases of aging, today ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Corin announced FDA clearance of its Unity Knee medial ...
CIRENCESTER, UNITED KINGDOM, October 28, 2024 /EINPresswire.com/ -- Corin today announced the first clinical use of its new Unity Knee™ Medial Constrained (MC ...
SAN FRANCISCO, July 30, 2019 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing, halting or reversing ...
UBX0101 failed to meet 12-week primary endpoint Guidance for UNITY’s Bcl-xL inhibitor UBX1325 in retinal disease remains unchanged UNITY to focus senescence programs on ophthalmologic and neurologic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results